Major Late-Breaking Trials from EuroPCR 2024
Coronary Interventions
Interventions for Valvular Disease
Stents, scaffolds and DCB
TAVI
Hotline / Late-Breaking Trials
Theatre Bleu
Anchorperson: Bernard Prendergast
Spokesperson: Thomas Cuisset
Discussants: Sabine Bleiziffer, Robert Byrne, Davide Capodanno, Nieves Gonzalo, Martin Leon, Gunasekaran Sengottuvelu, Stephan Windecker
One-month DAPT followed by 5-month Ticagrelor monotherapy in acute coronary syndromes with DCB
Ling Tao
Short methodology insight
Robert Byrne
Discussion and audience interaction
Impact in practice
Thomas Cuisset
First TAVI vs. SAVR randomised trial in younger low-risk patients with severe tricuspid or bicuspid aortic valve stenosis - results from NOTION-2
Ole De Backer
Short methodology insight
Davide Capodanno
Discussion and audience interaction
Impact in practice
Sabine Bleiziffer
Early outcomes of a randomised non-inferiority trial comparing TAVI devices: the LANDMARK trial
Patrick Serruys
Short methodology insight
Davide Capodanno
Discussion and audience interaction
Impact in practice
Martin Leon
